DMAC· Diamedica Therapeutics Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 0 | $0 |
Quarterly ownership history
Last 4 quarters
DMAC Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$341M
Enterprise value$289M
EV / EBITDA (TTM)-7.89
P/E ratio (TTM)—
Forward P/E-7.52
P/S ratio—
P/B ratio6.05
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$31M
Free cash flow (TTM)-$18M
Total cash$51M
Total debt$212K
Debt / equity0.45
Current ratio9.11
Income Statement
Total revenue (TTM)—
Revenue per share (TTM)—
Gross profit (TTM)—
EBITDA (TTM)-$37M
Net income (TTM)-$35M
EPS diluted (TTM)-0.71
Shares outstanding53,883,345
Float shares28,428,853
Profitability
Gross margin0.00%
Operating margin0.00%
EBITDA margin0.00%
Net margin0.00%
Efficiency
Return on assets (TTM)-49.96%
Return on equity (TTM)-86.47%
Price History
Current price$6.32
52 Week high$10.42
52 Week low$3.48
50 day average$6.79
200 day average$7.08
Average volume (10 day)180,840
1-year beta0.99
1-year price target$15.50
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:37 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com